Nasdaq warns Evogene of delisting risk due to low share price
In Israel, Evogene Ltd. received a letter from the Nasdaq Stock Market LLC indicating that the company is currently not in compliance with Nasdaq Rule 5550(a)(2), as the company’s closing bid price for its ordinary shares has been below $1.00 per share for the last 30 consecutive business days. The Nasdaq Stock Market Rules provide […]
